{
    "nctId": "NCT04024267",
    "briefTitle": "Eurythmy Therapy (ERYT) as a Treatment Option for Fatigue in Metastatic Breast Cancer Patients",
    "officialTitle": "Eurythmy Therapy (ERYT) as a Treatment Option for Fatigue in Metastatic Breast Cancer Patients",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Fatigue, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 196,
    "primaryOutcomeMeasure": "Change from baseline in fatigue over the whole intervention",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female, aged 18 years or older\n* Histologically or cytologically confirmed metastatic breast cancer\n* FACIT-F subscale score \\< 34 (considered as cut-off for a diagnosis of relevant fatigue; a score \\< 30 is considered as severe fatigue \\[83\\])\n* Eastern Cooperative Oncology Group (ECOG) grade 1 or 2\n* Ability to physically and cognitively perform an active movement therapy\n* Ability to provide informed consent as documented by signature\n* Ability to read, write, and speak German, French, or Italian\n\nExclusion Criteria:\n\n* Inability or contraindication that would prevent prolonged follow-up, or to undergo the investigated intervention or control intervention, in the opinion of the investigator\n* Patients with psychiatric, addictive or any disorder that prevents the patient from adhering to the protocol requirements, in the opinion of the investigator\n* Significant uncontrolled cardiac disease (e.g. unstable angina, recent myocardial infarction)\n* Haemoglobin \\< 90 g/L",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}